FDA approves Novartis biosimilar to Amgen's Enbrel

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news